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Previewsp53 aerobics: The major tumor suppressor fuels
your workout
In addition to its role as the central regulator of the cellular stress response, p53 can regulate aerobic respiration via
the novel transcriptional target SCO2, a critical regulator of the cytochrome c oxidase complex (Matoba et al., 2006). Loss
of p53 results in decreased oxygen consumption and aerobic respiration and promotes a switch to glycolysis, thereby
reducing endurance during physical exercise.p53, often referred to as the ‘‘guardian of
the genome,’’ is the most commonly
mutated gene in human cancer (Vogel-
stein et al., 2000). In response to DNA
damage or other types of stress, p53
acts as a sequence-specific transcrip-
tion factor and orchestrates the appro-
priate cellular response by inducing cell
cycle arrest, apoptosis, senescence, or
differentiation. While most p53 studies
have focused on its role as a tumor sup-
pressor, recent work suggests that p53
might play a role in other aspects of
mammalian life, including metabolism
as reported by Matoba et al. (2006) in
Science. Most cancer cells display al-
tered energy metabolism, primarily uti-
lizing glycolysis rather than the more
efficient aerobic respiration for their
energy needs, a switch known as the
Warburg Effect (Warburg, 1930). Al-
though Warburg’s classic hypothesis
that cancer results from a change in cel-
lular metabolism has been questionable,
his observation of increased glycolysis
in cancer is commonly used in clinical
practice where positron emission tech-
nology (PET) scanning is used to detect
tumors through their increased incorpo-
ration of the glucose analog 18fluoro-
deoxyglucose tracer (Gambhir, 2002).
Based on the hypothesis that an alter-
ation in the most commonly disturbed
pathway in cancer might cause meta-
bolic changes in cancer cells, Matoba
et al. (2006) found that p53 plays a direct
role in the assembly of the cytochrome c
oxidase complex, the major site of oxy-
gen utilization in the eukaryotic cell.
To test their hypothesis, the authors
initially looked at oxygen-consumption
and ATP production in both mice and
cell lines with hetero- and homozygous
loss of p53 and show that p53 loss re-
sults in a dose-dependent defect in oxy-
gen consumption, suggesting decreased
mitochondrial respiration. Overall ATP
production is not altered and lactic acid
levels increase with loss of p53, indicat-CELL METABOLISM 4, 1–8, JULY 2006 ª2006ing that glycolysis compensates for the
reduction in aerobic energy production.
Strikingly, p532/2 mice, while having
nearly identical body composition and
overall ATP production as wild-type mice,
have a marked decrease in exercise
stamina as shown by a swim stress test
(Matoba et al., 2006). These results sug-
gest that p53 plays a crucial role in ensur-
ing efficient ATP production by aerobic
respiration for prolonged exercise (see
Figure 1). How does a tumor suppressor
involved in cell cycle control and apopto-
sis regulate energy metabolism? The
canonical p53 targets could not explain
this glycolytic switch, but careful analysis
of p53 expression databases led the au-
thors to identify SCO2 (Synthesis of Cy-
tochrome c Oxidase 2) as a gene upregu-
lated in a p53-dependent manner. SCO2
is required for the assembly of a critical
component of the COXII complex, and
mutations in the gene result in aerobic re-
spiratory failure. The authors establish
SCO2 as a transcriptional target for p53
and demonstrate that p53 loss leads to
reduced levels of SCO2 expression in
both mice and cell lines. Rescue of en-
dogenous SCO2 levels by expression
of exogenous SCO2 in p53-deficient
cells restores aerobic respiration, estab-
lishing the biological relevance of this
regulatory circuit. Hetero- or homozy-
gous deletion of SCO2 phenocopies the
impaired respiration in p53 deficient
cells, indicating that p53 directly regu-
lates mitochondrial respiration through
SCO2.
The observation that cells with mutated
p53 have impaired respiration could have
profound effects on cancer cells, as they
require large amounts of energy to allow
for continuous uncontrolled proliferation.
Loss of p53 and the resulting SCO2-
dependent reduction in oxidative respira-
tion might drive cells into glycolysis in
order to support increased ATP demand.
During tumor growth, cells distal to vas-
culature have limited oxygen supply,ELSEVIER INC.and switching to glycolysis may give
these cells a growth advantage, allowing
them to continue to proliferate before
the onset of angiogenesis. A role in con-
trolling cancer cell metabolism comple-
ments recent advances in the p53 field
that started to establish the protein as
a central control point for stress and nutri-
ent response networks in addition to its
role in cell cycle control and apoptosis
(reviewed by Levine et al., 2006). p53,
IGF-1/AKT and TOR are all involved in
sensing and integrating nutrient and
stress signals and their cross-talk allows
an intricate regulation of cell-growth, pro-
liferation and programmed cell death.
The study by Matoba et al. (2006) identi-
fied SCO2 as the first direct transcrip-
tional target of p53 that modulates energy
metabolism, adding a layer of complexity
by connecting the stress response to
energy metabolism. To determine the
molecular mechanisms of complicated
biological processes such as aging and
tumor development, the cross-talk be-
tween these pathways will need to be fur-
ther dissected.
The p53-SCO2-respiration axis that
connects the tumor suppressor to me-
tabolism is an intriguing addition to the
long-established connection between
the metabolic state of an organism and
cancer development. Calorie restriction
(CR) has long been known to negatively
regulate both tumor formation, growth,
and development (reviewed by Hursting
et al., 2003). This observation has been
of great interest, as CR has also been
established as the only exogenous way
to extend the lifespan of a number of or-
ganisms, including yeast, worms, flies,
and rodents (reviewed by Bordon and
Guarente, 2005). Members of the SIR2
protein family (Sirtuins), originally identi-
fied in yeast, have emerged as key
players in regulating longevity, their en-
zymatic activity being regulated by the
NAD/NADH ratio within the cell. Mamma-
lian Sirtuins regulate a number of proteins1
P R E V I E W SFigure 1. Mice that are wild-type for p53 primarily use aerobic respiration for the production of ATP, a more efficient way to generate energy for physical activity than
glycolysis
p53 regulates the energy metabolism by transcription of SCO2, promoting the assembly of the cytochrome c oxidase complex (COXII). In mice with homozygous
deletion of p53, the level of SCO2 is low, thereby preventing COXII assembly and concomitant decreased aerobic respiration, promoting the switch to glycolysis.
Glycolytic energy production is not sufficient to generate ATP for prolonged exercise, resulting in premature exhaustion.involved in metabolism and the stress re-
sponse, including p53 (Luo et al., 2001;
Vaziri et al., 2001) and the Forkhead tran-
scription factors (Brunet et al., 2004;
Motta et al., 2004). It will be interesting
to see whether SIRT1, the mammalian
SIR2 analog, can modulate the p53-
dependent expression of SCO2 and
thereby regulate the switch from aerobic
respiration to glycolysis.
It has been argued that the metabolic
switch to glycolysis and an acquired
acid resistance of cancer cells could
yield a powerful growth advantage, pro-
moting unconstrained proliferation and
invasion (Gatenby and Gilles, 2004) and
the data presented by Matoba et al.
(2006) suggest that loss of p53 might
contribute to this acquired growth ad-
vantage. Hanahan and Weinberg have
described evading apoptosis, self-suffi-
ciency in growth signals, insensitivity to
anti-growth signals, issue invasion/me-
tastasis, limitless replicative potential,
and sustained angiogenesis as the six
hallmarks of cancer development (Hana-
han and Weinberg, 2000). While a loss of
p53 has long-established roles in the
evasion of apoptosis and the regula-
tion of replicative potential via cell cycle
control, the connection of p53 to the2regulation of metabolism constitutes a
new aspect of how p53 loss and changes
in energy metabolism in general might
affect tumor cell growth. This raises the
possibility that the energetic switch
from aerobic respiration to glycolysis
adds an additional hallmark of cancer
development or could provide further ex-
planations for existing ones, such as the
limitless replicative potential or insensi-
tivity to anti-growth signals. Demonstrat-
ing a direct metabolic target for p53
could be of great interest for cancer
treatment, as the switch to glycolysis is
predominantly observed in cancer cells.
Specific activation of p53, for example
by drugs like Nutlin-3 (Vassilev et al.,
2004), could result not only in targeting
its cell cycle and apoptotic responses,
but it could also prevent or inhibit the
glycolytic metabolism of cancer. It will
be interesting to see whether metabolic
changes can be observed in cancer pa-
tients with mutations for p53 and whether
tumors from these patients have reduced
SCO2 and aerobic respiration levels. It
would also be intriguing to know whether
the loss of functional p53 in humans also
reduces their energy and exercise poten-
tial as seen in mice. The study by Matoba
et al. (2006) adds aerobic respiration andendurance control to the already exten-
sive array of p53 functions, establishing
that p53 may be more than ‘‘the guardian
of the genome.’’
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